Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qi Niu

Showing results (191-200 of 194) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 194 results.
Theranostics|January 2, 2015
Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferonFeng-Qin Hou, Liu-Wei Song, Quan Yuan, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 15, 2020
Efficacy and safety of elbasvir/grazoprevir in treatment-naive Chinese adults with hepatitis C virus infection: A randomized trialLai Wei, Ji Dong Jia, Zhong Ping Duan, et al.
Journal of Gastroenterology and Hepatology|January 31, 2018
Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in ChinaLai Wei, Qing Xie, Jin Lin Hou, et al.
Translational Neurodegeneration|February 16, 2021
Recommendations for the diagnosis and treatment of paroxysmal kinesigenic dyskinesia: an expert consensus in ChinaLi Cao, Xiaojun Huang, Ning Wang, et al.
Pageof 20

Showing results (191-200 of 194) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 194 results.
Theranostics|January 2, 2015
Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferonFeng-Qin Hou, Liu-Wei Song, Quan Yuan, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 15, 2020
Efficacy and safety of elbasvir/grazoprevir in treatment-naive Chinese adults with hepatitis C virus infection: A randomized trialLai Wei, Ji Dong Jia, Zhong Ping Duan, et al.
Journal of Gastroenterology and Hepatology|January 31, 2018
Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in ChinaLai Wei, Qing Xie, Jin Lin Hou, et al.
Translational Neurodegeneration|February 16, 2021
Recommendations for the diagnosis and treatment of paroxysmal kinesigenic dyskinesia: an expert consensus in ChinaLi Cao, Xiaojun Huang, Ning Wang, et al.
Pageof 20